Medicus Pharma Ltd.
MDCX
$2.17
-$0.05-2.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 46.68% | 193.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.36% | 118.08% | |||
| Operating Income | -17.36% | -118.08% | |||
| Income Before Tax | -21.04% | -124.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -21.04% | -124.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.04% | -124.32% | |||
| EBIT | -17.36% | -118.08% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -3.74% | -108.30% | |||
| Normalized Basic EPS | -3.72% | -108.23% | |||
| EPS Diluted | 48.33% | -318.19% | |||
| Normalized Diluted EPS | -3.72% | -108.23% | |||
| Average Basic Shares Outstanding | 16.70% | 7.70% | |||
| Average Diluted Shares Outstanding | 16.70% | 7.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||